Ingelsson Erik, Larson Martin G, Yin Xiaoyan, Wang Thomas J, Meigs James B, Lipinska Izabella, Benjamin Emelia J, Keaney John F, Vasan Ramachandran S
The Framingham Study, Boston University School of Medicine, Framingham, Massachusetts 01702-5803, USA.
J Clin Endocrinol Metab. 2008 Aug;93(8):3149-57. doi: 10.1210/jc.2008-0207. Epub 2008 May 20.
The conjoint effects and relative importance of ghrelin, leptin, and soluble leptin receptor (sOB-R), adipokines involved in appetite control and energy expenditure in mediating cardiometabolic risk, is unknown.
The objective of the study was to study the cross-sectional relations of these adipokines to cardiometabolic risk factors in a community-based sample.
DESIGN, SETTING, AND PARTICIPANTS: We measured circulating ghrelin, leptin, and sOB-R in 362 participants (mean age 45 yr; 54% women) of the Framingham Third Generation Cohort.
Body mass index, waist circumference (WC), blood pressure, lipid measures, fasting glucose, smoking, and metabolic syndrome (MetS) were measured.
Ghrelin and leptin concentrations were significantly higher in women (P < 0.0001). In multivariable models, ghrelin was inversely associated with age and systolic blood pressure, and leptin was positively related to body mass index and WC. sOB-R was positively associated with age, total cholesterol, and fasting glucose and inversely with WC and high-density lipoprotein cholesterol. Ghrelin and sOB-R concentrations were significantly lower with number of MetS components (P for trend = 0.022 and < 0.0001, respectively), whereas leptin concentrations were higher (P for trend = 0.0001). Relating all adipokines to MetS conjointly, higher ghrelin and leptin concentrations were associated with decreased and increased odds of MetS (odds ratio 0.55, P < 0.0001; odds ratio 4.44, P = 0.0002, per 1 sd increase of respective log adipokine).
In our community-based sample, we observed a sexual dimorphism in circulating ghrelin and leptin concentrations. Ghrelin, leptin, and sOB-R were associated with number of MetS components cross-sectionally, consistent with the hypothesis that these adipokines may have a central role in cardiometabolic risk.
胃饥饿素、瘦素和可溶性瘦素受体(sOB-R)这些参与食欲控制和能量消耗的脂肪因子在介导心脏代谢风险中的联合作用及相对重要性尚不清楚。
本研究的目的是在一个基于社区的样本中研究这些脂肪因子与心脏代谢风险因素的横断面关系。
设计、地点和参与者:我们测量了弗雷明汉第三代队列研究中362名参与者(平均年龄45岁;54%为女性)的循环胃饥饿素、瘦素和sOB-R水平。
测量体重指数、腰围(WC)、血压、血脂指标、空腹血糖、吸烟情况和代谢综合征(MetS)。
女性的胃饥饿素和瘦素浓度显著更高(P<0.0001)。在多变量模型中,胃饥饿素与年龄和收缩压呈负相关,瘦素与体重指数和腰围呈正相关。sOB-R与年龄、总胆固醇和空腹血糖呈正相关,与腰围和高密度脂蛋白胆固醇呈负相关。胃饥饿素和sOB-R浓度随MetS组分数量的增加而显著降低(趋势P值分别为0.022和<0.0001),而瘦素浓度则更高(趋势P值=0.0001)。将所有脂肪因子联合起来与MetS相关分析,较高的胃饥饿素和瘦素浓度分别与MetS发生几率的降低和增加相关(优势比0.55,P<0.0001;优势比4.44,P=0.0002,各自对数脂肪因子每增加1个标准差)。
在我们基于社区的样本中,我们观察到循环胃饥饿素和瘦素浓度存在性别差异。胃饥饿素、瘦素和sOB-R与MetS组分数量存在横断面关联,这与这些脂肪因子可能在心脏代谢风险中起核心作用的假设一致。